MANKIND

Mankind Pharma Share Price

 

 

Invest in Mankind Pharma with 3.56X leverage

Invest with MTF

Performance

  • Low
  • ₹2,173
  • High
  • ₹2,201
  • 52 Week Low
  • ₹2,090
  • 52 Week High
  • ₹2,998
  • Open Price₹2,201
  • Previous Close₹2,193
  • Volume294,610

Investment Returns

  • Over 1 Month -3.07%
  • Over 3 Month -12.12%
  • Over 6 Month -6.49%
  • Over 1 Year -24.02%

Smart Investing Starts Here Start SIP with Mankind Pharma for Steady Growth!

Invest Now

Mankind Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 51.4
  • PEG Ratio
  • -3
  • Market Cap Cr
  • 90,074
  • P/B Ratio
  • 5.9
  • Average True Range
  • 41.63
  • EPS
  • 42.36
  • Dividend Yield
  • 0
  • MACD Signal
  • -32.98
  • RSI
  • 45.35
  • MFI
  • 42.61

Mankind Pharma Financials

Mankind Pharma Technicals

EMA & SMA

Current Price
₹2,182.00
-11 (-0.5%)
pointer
  • Bearish Moving Average 12
  • Bullish Moving Average 4
  • 20 Day
  • ₹2,191.09
  • 50 Day
  • ₹2,260.53
  • 100 Day
  • ₹2,338.04
  • 200 Day
  • ₹2,389.49

Resistance and Support

2185.2 Pivot Speed
  • R3 2,225.00
  • R2 2,212.80
  • R1 2,197.40
  • S1 2,169.80
  • S2 2,157.60
  • S3 2,142.20

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Mankind Pharma Ltd. is one of India’s largest pharmaceutical companies, providing a wide range of affordable medicines in areas like antibiotics, cardiovascular, gastrointestinal, and dermatology. It also manufactures over-the-counter (OTC) products, catering to domestic and global markets.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Mankind Pharma Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-06 Quarterly Results
2025-07-31 Quarterly Results & Interim Dividend
2025-05-21 Audited Results
2025-01-23 Quarterly Results
2024-11-05 Quarterly Results
Date Purpose Remarks
2025-08-08 INTERIM Rs.1.00 per share(100%)Interim Dividend
View Mankind Pharma Dividend History Arrow

Mankind Pharma F&O

Mankind Pharma Shareholding Pattern

72.67%
7.78%
1.77%
12.83%
0%
1.36%
3.59%

Mankind Pharma FAQs

Mankind Pharma share price is ₹2,182 As on 30 December, 2025 | 01:26

The Market Cap of Mankind Pharma is ₹90074.1 Cr As on 30 December, 2025 | 01:26

The P/E ratio of Mankind Pharma is 51.4 As on 30 December, 2025 | 01:26

The PB ratio of Mankind Pharma is 5.9 As on 30 December, 2025 | 01:26

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23